Amgen Taps GSK's Stiefel Unit To Promote Enbrel To Dermatologists
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal will aid Amgen's promotional efforts around Enbrel in psoriasis as the entrenched biologic faces down Humira, Stelara in the market.